Method for treating shingles with N-methanocarbathymidine (N-MCT)
US10758536B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2016 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | May 3, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application discloses a method of treating a Varicella-Zoster Virus (VZV) infection in an individual in need thereof, including the step of administering to said individual an effective Varicella-Zoster Virus antiviral amount of a compound called N-methanocarbathymidine (N-MCT), which has a northern configuration with the structure as follows
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.